β-globin gene transfer to human bone marrow for sickle cell disease
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
β-globin gene transfer to human bone marrow for sickle cell disease
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL INVESTIGATION
Volume 123, Issue 8, Pages 3317-3330
Publisher
American Society for Clinical Investigation
Online
2013-06-30
DOI
10.1172/jci67930
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Unrelated Donor Cord Blood Transplantation for Children with Severe Sickle Cell Disease: Results of One Cohort from the Phase II Study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN)
- (2012) Naynesh R. Kamani et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Gene therapy for adenosine deaminase-deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans
- (2012) F. Candotti et al. BLOOD
- Allogeneic hematopoietic stem cell transplantation in children with sickle cell disease
- (2012) Franco Locatelli et al. PEDIATRIC BLOOD & CANCER
- Therapeutic Hemoglobin Levels after Gene Transfer in β-Thalassemia Mice and in Hematopoietic Cells of β-Thalassemia and Sickle Cells Disease Patients
- (2012) Laura Breda et al. PLoS One
- Highly efficient large-scale lentiviral vector concentration by tandem tangential flow filtration
- (2011) Aaron R. Cooper et al. JOURNAL OF VIROLOGICAL METHODS
- Hematopoietic Stem Cell Transplantation for Sickle Cell Disease: Current Practice and Emerging Trends
- (2011) S. Shenoy Hematology-American Society of Hematology Education Program
- Current status of globin gene therapy for the treatment of β-thalassaemia
- (2010) Leszek Lisowski et al. BRITISH JOURNAL OF HAEMATOLOGY
- Quantitatively different red cell/nucleated cell chimerism in patients with long-term, persistent hematopoietic mixed chimerism after bone marrow transplantation for thalassemia major or sickle cell disease
- (2010) M. Andreani et al. HAEMATOLOGICA
- Sickle-cell disease
- (2010) David C Rees et al. LANCET
- Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia
- (2010) Marina Cavazzana-Calvo et al. NATURE
- Genome-wide high-throughput integrome analyses by nrLAM-PCR and next-generation sequencing
- (2010) Anna Paruzynski et al. Nature Protocols
- Insulators and promoters: closer than we think
- (2010) Jesse R. Raab et al. NATURE REVIEWS GENETICS
- A novel human gamma-globin gene vector for genetic correction of sickle cell anemia in a humanized sickle mouse model: critical determinants for successful correction
- (2009) A. Perumbeti et al. BLOOD
- The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS)
- (2009) E. Voskaridou et al. BLOOD
- Blood and marrow transplantation for sickle cell disease: overcoming barriers to success
- (2009) Javier Bolaños-Meade et al. CURRENT OPINION IN ONCOLOGY
- Granulocyte colony-stimulating factor (G-CSF) administration in individuals with sickle cell disease: time for a moratorium?
- (2009) Courtney D. Fitzhugh et al. CYTOTHERAPY
- Epigenetic Silencing of the p16INK4a Tumor Suppressor Is Associated with Loss of CTCF Binding and a Chromatin Boundary
- (2009) Michael Witcher et al. MOLECULAR CELL
- Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy
- (2009) N. Cartier et al. SCIENCE
- Ultrafast and memory-efficient alignment of short DNA sequences to the human genome
- (2009) Ben Langmead et al. GENOME BIOLOGY
- Stable Long-Term Donor Engraftment following Reduced-Intensity Hematopoietic Cell Transplantation for Sickle Cell Disease
- (2008) Lakshmanan Krishnamurti et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Correction of Murine Sickle Cell Disease Using γ-Globin Lentiviral Vectors to Mediate High-level Expression of Fetal Hemoglobin
- (2008) Tamara I Pestina et al. MOLECULAR THERAPY
- In vivo selection of genetically modified erythroblastic progenitors leads to long-term correction of -thalassemia
- (2008) A. Miccio et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search